These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 22327827

  • 1. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
    Soyoral YU, Demir C, Begenik H, Esen R, Kucukoglu ME, Aldemir MN, Demirkiran D, Erkoc R.
    Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
    [Abstract] [Full Text] [Related]

  • 2. The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients.
    Brophy DF, Martin EJ, Carr SL, Kirschbaum B, Carr ME.
    Thromb Res; 2007; 119(6):723-9. PubMed ID: 16793120
    [Abstract] [Full Text] [Related]

  • 3. Platelet dysfunction and end-stage renal disease.
    Kaw D, Malhotra D.
    Semin Dial; 2006; 19(4):317-22. PubMed ID: 16893410
    [Abstract] [Full Text] [Related]

  • 4. The effect of recombinant human erythropoietin on hemostatic status in chronic uremic patients.
    Tsao CJ, Kao RH, Cheng TY, Huang CC, Chang SL, Lee FN.
    Int J Hematol; 1992 Apr; 55(2):197-203. PubMed ID: 1511168
    [Abstract] [Full Text] [Related]

  • 5. [Case of uremic platelet dysfunction].
    Ohzeki M, Fukushima T, Arakawa S, Ozeki M, Kosaka Y, Kobayashi S, Namikoshi T, Haruna Y, Sasaki T, Kashihara N.
    Nihon Jinzo Gakkai Shi; 2005 Apr; 47(7):834-8. PubMed ID: 16296414
    [Abstract] [Full Text] [Related]

  • 6. [Modification of uremic thrombocytopathy by hemodialysis].
    Frick U, Frick G, Vitu J, Wiedenhöft I.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983 Apr; 110(2):309-13. PubMed ID: 6194064
    [Abstract] [Full Text] [Related]

  • 7. Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients.
    Lee HK, Kim YJ, Jeong JU, Park JS, Chi HS, Kim SB.
    Nephron Clin Pract; 2010 Apr; 114(4):c248-52. PubMed ID: 20090366
    [Abstract] [Full Text] [Related]

  • 8. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis.
    Mahajan S, Kalra OP, Asit KT, Ahuja G, Kalra V.
    Ren Fail; 2005 Apr; 27(4):357-60. PubMed ID: 16060119
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of platelet hemostasis in patients with chronic renal failure].
    Krawczyk W, Dmoszyńska A, Sokołowska B.
    Wiad Lek; 1994 Feb; 47(3-4):93-9. PubMed ID: 7975649
    [Abstract] [Full Text] [Related]

  • 10. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
    Salvati F, Liani M.
    Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
    [Abstract] [Full Text] [Related]

  • 11. Desmopressin improves platelet function in uremic patients taking antiplatelet agents who require emergent invasive procedures.
    Kim JH, Baek CH, Min JY, Kim JS, Kim SB, Kim H.
    Ann Hematol; 2015 Sep; 94(9):1457-61. PubMed ID: 25933676
    [Abstract] [Full Text] [Related]

  • 12. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
    Terawaki H, Nakayama K, Matsuyama Y, Nakayama M, Sato T, Hosoya T, Era S, Ito S.
    Blood Purif; 2007 Sep; 25(3):274-9. PubMed ID: 17460395
    [Abstract] [Full Text] [Related]

  • 13. Hemodialysis shortens long in vitro closure times as measured by the PFA-100.
    Bilgin AU, Karadogan I, Artac M, Kizilors A, Bligin R, Undar L.
    Med Sci Monit; 2007 Mar; 13(3):CR141-5. PubMed ID: 17325638
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation.
    Escolar G, Cases A, Viñas M, Pino M, Calls J, Cirera I, Ordinas A.
    Haematologica; 1999 Jul; 84(7):614-9. PubMed ID: 10406903
    [Abstract] [Full Text] [Related]

  • 15. Platelet factor 3 in normal subjects and patients with renal failure.
    Rabiner SF, Hrodek O.
    J Clin Invest; 1968 Apr; 47(4):901-12. PubMed ID: 5641625
    [Abstract] [Full Text] [Related]

  • 16. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S, Barbano B, Cianci R, Gigante A, Di Donato D, Asllanaj B, Dimko M, Mariotti A, Morabito S, Pugliese F.
    G Ital Nefrol; 2010 Apr; 27(6):649-54. PubMed ID: 21132647
    [Abstract] [Full Text] [Related]

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 18. [Effects of the treatment with human recombinant erythropoietin on primary hemostasis in uremic patients].
    Cases A, Escolar G, Reverter JC, Garrido M, Ordinas A, López-Pedret J, Castillo R, Revert L.
    Med Clin (Barc); 1990 Nov 17; 95(17):644-7. PubMed ID: 2089202
    [Abstract] [Full Text] [Related]

  • 19. Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients.
    Khedmat H, Ahmadzad-Asl M, Amini M, Lessan-Pezeshki M, Einollahi B, Pourfarziani V, Naseri MH, Davoudi F.
    Transplant Proc; 2007 May 17; 39(4):1003-7. PubMed ID: 17524875
    [Abstract] [Full Text] [Related]

  • 20. Effect of hemodialysis on platelet function in end-stage renal disease Egyptian patients using in vitro closure time test (PFA-100 analyzer).
    Mekawy MA, Habashy DM, Abd El-Mohsen WA.
    Platelets; 2015 May 17; 26(5):443-7. PubMed ID: 24955720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.